SMIM22 and neoplasm: Although the mechanisms by which SMIM22 regulates lipid biogenesis remain unclear, its upregulation in cancers such as non-small-cell lung cancer and hepatocellular carcinoma raises the possibility that it may contribute to tumor progression through effects on lipid metabolism.